Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 8/20 | 0.40 |
| ▸ | PYGL | P06737 | 3/20 | 0.39 |
| ▸ | PYGM | P11217 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29732640 | 0.81 | PYGB (0.43) | PYGBPYGLPYGM | |
| SCHEMBL8216944 | 0.81 | PYGB (0.43) | PYGBPYGLPYGM | |
| SCHEMBL3458192 | 0.81 | PYGB (0.43) | PYGBPYGLPYGM | |
| SCHEMBL8510122 | 0.81 | PYGB (0.43) | PYGBPYGLPYGM | |
| SCHEMBL9296731 | 0.81 | PYGB (0.43) | PYGBPYGLPYGM | |
| SCHEMBL2590390 | 0.77 | PYGB (0.43) | PYGBPYGLPYGM | |
| Acetic Acid SCHEMBL30370283 | 0.73 | PYGB (0.42) | PYGBPYGLPYGM | |
| SCHEMBL23358401 | 0.69 | PYGB (0.44) | PYGBPYGLPYGM | |
| SCHEMBL18820165 | 0.69 | PYGB (0.44) | PYGBPYGLPYGM | |
| SCHEMBL5062195 | 0.69 | PYGB (0.48) | PYGBPYGLPYGM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018142422-A1 | PROCESS FOR THE PREPARATION OF DAPAGLIFLOZIN | INDOCO REMEDIES LIMITED (IN) | 2018-08-09 | — | — | WO | disclosed |
| US-20180016290-A1 | PROCESS FOR THE PREPARATION OF SGLT INHIBITOR COMPOUNDS | INDOCO REMEDIES LIMITED (IN) | 2018-01-18 | — | — | US | disclosed |
| EP-3256482-A1 | PROCESS FOR THE PREPARATION OF SGLT INHIBITOR COMPOUNDS | Indoco Remedies Limited (IN) | 2017-12-20 | — | — | EP | disclosed |
| WO-2016128995-A1 | PROCESS FOR THE PREPARATION OF SGLT INHIBITOR COMPOUNDS | INDOCO REMEDIES LIMITED (IN) | 2016-08-18 | — | — | WO | disclosed |
| US-6093805-A | AGLYCON COMPOUNDS HAVING HYDROXY, MERCAPTO, OR CARBOXY GROUP AND LINKED TO MONO- AND DISACCHARIDES HAVING 2,3-DIDEOXY-ALPHA-D-ERYTHRO-HEX-2-ENOPYRANOSIDE MOIETY; BETTER PHARMACOLOGICAL PROPERTIES INCLUDING WATER SOLUBILITY | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2000-07-25 | — | — | US | disclosed |
| EP-0594581-B1 | PRODUCTION OF GLYCOSIDES, ESPECIALLY OF STEROIDAL GLYCOSIDES | KLEMKE RUDOLF ERICH (DE) | 1998-07-01 | — | — | EP | disclosed |
| US-5693767-A | 2,3-DIDEOXY-ALPHA-D-ERYTHRO-HEX-2-ENOPYRANOSIDE DERIVATIVE OF ACETAMINOPHEN; WATER SOLUBILITY | HARRIER INC. (US) | 1997-12-02 | — | — | US | disclosed |
| US-5278296-A | Production of hydroxysteryl glycoside compounds | GELMAN SCIENCES INC. (US) | 1994-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180016290-A1 | PROCESS FOR THE PREPARATION OF SGLT INHIBITOR COMPOUNDS | SLC5A2, SLC5A1, SLC2A9 | PYGB 1019/4885PYGL 645/4885PYGM 1232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.